The Blake McMillan Trust is proud to be a part of the global community to Reverse MECP2. 

Reverse Rett funds research to speed treatments for Rett Syndrome, MECP2 Duplication Syndrome, and other MECP2-related gene disorders. Reverse Rett has designated the Reverse MECP2 initiative to hold designated funds for MECP2 Duplication Syndrome research. 100% of the funds which are raised for Reverse MECP2 through Reverse Rett are delivered to MECP2 research focused projects every quarter.